Harmony Biosciences Holdings, Inc.(HRMY),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

HRMY Harmony Biosciences Holdings, Inc.

Market Closed 06-05 16:00:00 EDT

32.20

-0.76

-2.31%

盘后32.20

+0.000.00%

19:39 EDT

High33.20	Low32.06	Vol462.30K
Open33.00	D1 Closing32.96	Amplitude3.46%
Mkt Cap1.86B	Tradable Cap1.43B	Total Shares57.89M
T/O14.99M	T/O Rate1.04%	Tradable Shares44.56M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"HRMY","market":"US","secType":"STK","nameCN":"Harmony Biosciences Holdings, Inc.","latestPrice":32.2,"timestamp":1780689600000,"preClose":32.96,"halted":0,"volume":462299,"hourTrading":{"tag":"盘后","latestPrice":32.2,"preClose":32.2,"latestTime":"19:39 EDT","volume":10843,"amount":349135.56,"timestamp":1780702795087,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.023058252427184404,"floatShares":44560063,"shares":57892676,"eps":2.479777,"marketStatus":"Market Closed","change":-0.76,"latestTime":"06-05 16:00:00 EDT","open":33,"high":33.2,"low":32.06,"amount":14986302.302296001,"amplitude":0.034587,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":2.479777,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1780905600000},"marketStatusCode":7,"adr":0,"listingDate":1597809600000,"exchange":"NASDAQ","adjPreClose":32.96,"preHourTrading":{"tag":"盘前","latestPrice":32.51,"preClose":32.96,"latestTime":"07:51 EDT","volume":278,"amount":9101.87846,"timestamp":1780660310173,"change":-0.45,"changeRate":-0.013653,"amplitude":0.057646},"postHourTrading":{"tag":"盘后","latestPrice":32.2,"preClose":32.2,"latestTime":"19:39 EDT","volume":10843,"amount":349135.56,"timestamp":1780702795087,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.497374667906427,"impliedVol":0.7945,"impliedVolPercentile":0.8247},"requestUrl":"/m/hq/s/HRMY/tweets","defaultTab":"tweets","newsList":[{"id":"2640413172","title":"Looking Back at Stock Picks Hyatt Hotels, Sensient Technologies, Harmony Biosciences. What the Charts Say. -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2640413172","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640413172?lang=en_us&edition=fundamental","pubTime":"2026-06-04 13:14","pubTimestamp":1780550040,"startTime":"0","endTime":"0","summary":"Reviewing past stock picks is an essential part of the investment process. It provides a valuable opportunity to assess the accuracy of our analysis, learn from both successes and setbacks, and identify lessons that can improve future decisions.In this update, we revisit the following former stock recommendations and examine how they have performed since we first highlighted them:. -- Hyatt Hotels, written by Teresa Rivas last July.-- Sensient Technologies, introduced by Dan Victor in April.-- Harmony Biosciences, which Todd Chanko reviewed in March.This note revisits past stock picks where new developments favor fresh buy or sell signals. Read last week's edition here.Looking at the daily chart, the stock showed a significant improvement in relative strength in late April, breaking above a downtrend on its ratio chart versus the benchmark State Street Materials Select Sector SPDR ETF. The move followed a well-received earnings report, with shares surging 24% on April 24:. The stock re","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1894683264.USD","BK4135","HRMY","BK4007","IE00B3QW5Z07.USD","LU1883839398.USD","LU0061475181.USD","IE00B64PRP62.GBP","BK4109","BK4588","IE00BGHQF748.EUR","SXT","H","LU1894683348.USD","IE0034235188.USD","STT","IE0009354923.USD","BK4142","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638507727","title":"Harmony Biosciences to present at Goldman Sachs Global Healthcare Conference fireside chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2638507727","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638507727?lang=en_us&edition=fundamental","pubTime":"2026-05-27 20:05","pubTimestamp":1779883544,"startTime":"0","endTime":"0","summary":"Harmony Biosciences will join the Goldman Sachs 47th Annual Global Healthcare Conference on June 9, 2026, with a fireside chat at 8:40 a.m. ET.Management will also participate in the Oppenheimer CNS & Neuro-Muscular Summit on June 10, 2026, with a fireside chat at 3:25 p.m. ET.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Harmony Biosciences Holdings Inc. published the original content used to generate this news brief via Business Wire  on May 27, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nNDLbXVkvs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0004091025.USD","LU0868494617.USD","LU1868836757.USD","BK4533","BK4127","LU0345770308.USD","LU0742534661.SGD","LU1868837300.USD","LU2237443465.HKD","LU2471134796.USD","BK4552","LU2237443382.USD","LU2471134879.HKD","LU0345770993.USD","LU2471134523.USD","LU0251131958.USD","LU0942090050.USD","LU1668664300.SGD","BK4516","LU0251142724.SGD","HRMY","LU1868837136.USD","LU1868836914.USD","LU0061475181.USD","LU2237438978.USD","BK4588","LU2237443622.USD","LU0048573561.USD","LU1791807156.HKD","LU1868836591.USD","GSX","BK4504","LU1894683348.USD","BK4007","LU2471134952.CNY","LU2750360641.GBP","LU2237443549.SGD","IE00BFXG1179.USD","LU1804176565.USD","BK4585","LU0106831901.USD","LU0096364046.USD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","IE00BSNM7G36.USD","LU0868494708.USD","LU1894683264.USD","LU2237443895.HKD","BK4550","IE0004086264.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636100606","title":"Harmony Biosciences CFO Glenn Reicin files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2636100606","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636100606?lang=en_us&edition=fundamental","pubTime":"2026-05-19 04:13","pubTimestamp":1779135231,"startTime":"0","endTime":"0","summary":"Harmony Biosciences filed an initial beneficial ownership statement for CFO Glenn Reicin dated April 14, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Harmony Biosciences Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 18, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260518:nNDL6qRFBx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","HRMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635722363","title":"Harmony Biosciences Shareholders Approve Governance Measures at Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2635722363","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635722363?lang=en_us&edition=fundamental","pubTime":"2026-05-15 06:50","pubTimestamp":1778799029,"startTime":"0","endTime":"0","summary":"Harmony Biosciences Holdings ( ($HRMY) ) has provided an update. Harmony Biosciences Holdings, Inc. held its 2026 Annual Meeting of Stockholders on...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/harmony-biosciences-shareholders-approve-governance-measures-at-meeting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/harmony-biosciences-shareholders-approve-governance-measures-at-meeting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","HRMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634314284","title":"Analysts Offer Insights on Healthcare Companies: Harmony Biosciences Holdings (HRMY), Maravai Lifesciences Holdings (MRVI) and Alkermes (ALKS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2634314284","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634314284?lang=en_us&edition=fundamental","pubTime":"2026-05-11 20:50","pubTimestamp":1778503813,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Harmony Biosciences Holdings (HRMY), Maravai Lifes...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-harmony-biosciences-holdings-hrmy-maravai-lifesciences-holdings-mrvi-and-alkermes-alks-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-harmony-biosciences-holdings-hrmy-maravai-lifesciences-holdings-mrvi-and-alkermes-alks-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","LU0128526141.USD","HCSG","BK4585","ALKS","HRMY","LABU","BK4581","BK4588","MRVI","XLV","BK4137","LU0029874061.USD","XBI","BK4121","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634712465","title":"Harmony Biosciences Is Maintained at Hold by Truist Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2634712465","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634712465?lang=en_us&edition=fundamental","pubTime":"2026-05-09 01:17","pubTimestamp":1778260620,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/HRMY/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 08, 2026 13:17 ET (17:17 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","HRMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633457760","title":"Harmony Biosciences price target raised to $29 from $25 at Truist","url":"https://stock-news.laohu8.com/highlight/detail?id=2633457760","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633457760?lang=en_us&edition=fundamental","pubTime":"2026-05-08 22:41","pubTimestamp":1778251269,"startTime":"0","endTime":"0","summary":"Truist raised the firm’s price target on Harmony Biosciences (HRMY) to $29 from $25 and keeps a Hold rating on the shares after meeting with the co...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/harmony-biosciences-price-target-raised-to-29-from-25-at-truist-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/harmony-biosciences-price-target-raised-to-29-from-25-at-truist-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HRMY","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633126517","title":"Harmony Biosciences backs FY26 revenue view $1B-$1.04B, consensus $1.02B","url":"https://stock-news.laohu8.com/highlight/detail?id=2633126517","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633126517?lang=en_us&edition=fundamental","pubTime":"2026-05-07 22:35","pubTimestamp":1778164542,"startTime":"0","endTime":"0","summary":"07:39 EDT Harmony Biosciences (HRMY) backs FY26 revenue view $1B-$1.04B, consensus $1.02B Published first on TheFly – the ultimate source for real-...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/harmony-biosciences-backs-fy26-revenue-view-1b-1-04b-consensus-1-02b-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/harmony-biosciences-backs-fy26-revenue-view-1b-1-04b-consensus-1-02b-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","HRMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163371422","title":"Stock Track | Harmony Biosciences Plunges 5.43% in Pre-Market After Q1 Earnings Miss Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=1163371422","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163371422?lang=en_us&edition=fundamental","pubTime":"2026-05-07 20:39","pubTimestamp":1778157596,"startTime":"0","endTime":"0","summary":"Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) experienced a pre-market plunge of 5.43% on Thursday, following the release of its first-quarter financial results.The decline comes after the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["HRMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633149736","title":"GUIDANCE: (HRMY) Harmony Biosciences Expects 2026 WAKIX Net Revenue Range $1.0B - $1.04B","url":"https://stock-news.laohu8.com/highlight/detail?id=2633149736","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633149736?lang=en_us&edition=fundamental","pubTime":"2026-05-07 19:40","pubTimestamp":1778154052,"startTime":"0","endTime":"0","summary":"GUIDANCE: (HRMY) Harmony Biosciences Expects 2026 WAKIX Net Revenue Range $1.0B - $1.04B","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HRMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633149254","title":"Earnings Flash (HRMY) Harmony Biosciences Posts Q1 EPS $0.55, vs. FactSet Est of $0.69","url":"https://stock-news.laohu8.com/highlight/detail?id=2633149254","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633149254?lang=en_us&edition=fundamental","pubTime":"2026-05-07 19:40","pubTimestamp":1778154039,"startTime":"0","endTime":"0","summary":"Earnings Flash (HRMY) Harmony Biosciences Posts Q1 EPS $0.55, vs. FactSet Est of $0.69","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HRMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633492691","title":"Harmony Biosciences Q1 revenue rises less than expected","url":"https://stock-news.laohu8.com/highlight/detail?id=2633492691","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633492691?lang=en_us&edition=fundamental","pubTime":"2026-05-07 19:40","pubTimestamp":1778154026,"startTime":"0","endTime":"0","summary":"Harmony Biosciences Q1 revenue rises less than expectedOverviewU.S. rare disease drugmaker's Q1 product revenue rose 17% yr/yr but missed analyst expectationsQ1 net income fell yr/yr due to higher R&D","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nL1N41K0O1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","HRMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633149103","title":"Harmony Biosciences Q1 Adj. EPS $0.55 Misses $0.69 Estimate, Sales $215.400M Miss $225.227M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2633149103","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633149103?lang=en_us&edition=fundamental","pubTime":"2026-05-07 19:38","pubTimestamp":1778153884,"startTime":"0","endTime":"0","summary":"Harmony Biosciences (NASDAQ:HRMY) reported quarterly earnings of $0.55 per share which missed the analyst consensus estimate of $0.69 by 20.29 percent. This is a 46.6 percent decrease over earnings of $1.03 per share","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52361897/harmony-biosciences-q1-adj-eps-0-55-misses-0-69-estimate-sales-215-400m-miss-225-227m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","HRMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633498471","title":"BRIEF-Harmony Biosciences Q1 Net Income USD 32.488 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633498471","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633498471?lang=en_us&edition=fundamental","pubTime":"2026-05-07 19:30","pubTimestamp":1778153446,"startTime":"0","endTime":"0","summary":"May 07  - Harmony Biosciences Q1 product revenue USD 215.387 million vs. IBES estimate USD 225.2 million.Q1 pretax profit USD 39.687 million vs. IBES estimate USD 58.2 million","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nPLXE55074:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","HRMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633149646","title":"Harmony Biosciences: on Track to Achieve >$1 Bln in Narcolepsy Net Sales in 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2633149646","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633149646?lang=en_us&edition=fundamental","pubTime":"2026-05-07 19:30","pubTimestamp":1778153402,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nPLXE55074:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","HRMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633114988","title":"Harmony Biosciences Q1 Gross Profit USD 170.875 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633114988","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633114988?lang=en_us&edition=fundamental","pubTime":"2026-05-07 19:30","pubTimestamp":1778153402,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nPLXE55074:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HRMY","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633058146","title":"Harmony Biosciences Q1 Product Revenue USD 215.387 Million VS. Ibes Estimate USD 225.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633058146","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633058146?lang=en_us&edition=fundamental","pubTime":"2026-05-07 19:30","pubTimestamp":1778153402,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nPLXE55074:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","HRMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633414606","title":"Harmony Biosciences Reports Q1 Financial Results and Confirms 2026 Net Revenue Guidance of Over $1 Billion; Reinforces 2026 Strategic Priorities","url":"https://stock-news.laohu8.com/highlight/detail?id=2633414606","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633414606?lang=en_us&edition=fundamental","pubTime":"2026-05-07 19:30","pubTimestamp":1778153401,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nTUAXY3YJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","HRMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166819386","title":"Earning Preview: Harmony Biosciences Holdings, Inc. this quarter’s revenue is expected to increase by 24.26%, and institutional views are predominantly bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=1166819386","media":"Earnings Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166819386?lang=en_us&edition=fundamental","pubTime":"2026-04-30 17:57","pubTimestamp":1777543072,"startTime":"0","endTime":"0","summary":"Abstract Harmony Biosciences Holdings, Inc. will report quarterly results on May 7, 2026 Pre-Market; this preview outlines consensus expectations for revenue and earnings trends alongside near-term...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Earning Preview: Harmony Biosciences Holdings, Inc. this quarter’s revenue is expected to increase by 24.26%, and institutional views are predominantly bullish","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HRMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629839456","title":"Harmony Biosciences to report first-quarter results, host conference call and webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2629839456","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629839456?lang=en_us&edition=fundamental","pubTime":"2026-04-23 20:11","pubTimestamp":1776946274,"startTime":"0","endTime":"0","summary":"Harmony Biosciences scheduled release of first-quarter fiscal 2026 financial results for May 7, 2026, before US market open.Conference call, webcast set for May 7, 2026, at 8:30 a.m. ET.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nNDL2SpGvC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","HRMY"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.harmonybiosciences.com","stockEarnings":[{"period":"1week","weight":0.0193},{"period":"1month","weight":-0.0177},{"period":"3month","weight":0.1366},{"period":"6month","weight":-0.1916},{"period":"1year","weight":-0.0808},{"period":"ytd","weight":-0.1395}],"compareEarnings":[{"period":"1week","weight":-0.025},{"period":"1month","weight":0.0051},{"period":"3month","weight":0.0969},{"period":"6month","weight":0.0756},{"period":"1year","weight":0.2437},{"period":"ytd","weight":0.0816}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. It offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.","yearOnYearQuotes":[{"month":1,"riseRate":0.166667,"avgChangeRate":-0.035612},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.051691},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.016911},{"month":4,"riseRate":0.166667,"avgChangeRate":-0.04592},{"month":5,"riseRate":0.666667,"avgChangeRate":0.043963},{"month":6,"riseRate":0.666667,"avgChangeRate":-0.003175},{"month":7,"riseRate":0.8,"avgChangeRate":0.041515},{"month":8,"riseRate":0.8,"avgChangeRate":0.05943},{"month":9,"riseRate":0.5,"avgChangeRate":-0.023406},{"month":10,"riseRate":0.666667,"avgChangeRate":-0.006378},{"month":11,"riseRate":0.833333,"avgChangeRate":0.105341},{"month":12,"riseRate":0.5,"avgChangeRate":0.02881}],"exchange":"NASDAQ","name":"Harmony Biosciences Holdings, Inc.","nameEN":"Harmony Biosciences Holdings, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Harmony Biosciences Holdings, Inc.(HRMY),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Harmony Biosciences Holdings, Inc.(HRMY) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Harmony Biosciences Holdings, Inc.,HRMY,Harmony Biosciences Holdings, Inc.股票,Harmony Biosciences Holdings, Inc.股票老虎,Harmony Biosciences Holdings, Inc.股票老虎国际,Harmony Biosciences Holdings, Inc.行情,Harmony Biosciences Holdings, Inc.股票行情,Harmony Biosciences Holdings, Inc.股价,Harmony Biosciences Holdings, Inc.股市,Harmony Biosciences Holdings, Inc.股票价格,Harmony Biosciences Holdings, Inc.股票交易,Harmony Biosciences Holdings, Inc.股票购买,Harmony Biosciences Holdings, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Harmony Biosciences Holdings, Inc.(HRMY),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Harmony Biosciences Holdings, Inc.(HRMY) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction